期刊文献+

钙与维生素D_3抑制人宫颈癌细胞和组织增殖作用的相关性研究 被引量:3

Relationship between calcium and vitamin D_3 in inhibiting the proliferation of human cervical cancer cells and tissues
下载PDF
导出
摘要 目的:检测不同浓度与作用时间的钙离子(Ca2+)对HeLa细胞增殖与宫颈癌组织3H-TdR掺入的影响,同时检测维生素D3(VD3)的协同作用与维拉帕米(VP)的拮抗作用,探讨Ca2+抑制宫颈癌细胞与组织增殖的可能作用机制。方法:应用MTT法检测HeLa细胞在各作用因素存在时的增殖水平;应用同位素放射自显影检测新鲜人宫颈癌组织在各刺激因素存在时的3H-TdR掺入水平。结果:Ca2+具有抑制HeLa细胞增殖和宫颈癌组织3H-TdR掺入作用,VD3可明显协同增强Ca2+的抑制作用,VP可明显拮抗Ca2+的作用、部分拮抗VD3的协同作用。结论:Ca2+具有剂量与时间依赖性抑制宫颈癌细胞与组织增殖的作用,其作用机制与促进细胞外钙内流相关;VD3的协同抑制作用不仅与促进细胞外钙内流相关,还存在其它机制有待探讨。 Objective: To investigate the effects of different concentrations of calcium on cell proliferation in human cervical cancer cells and tissues at different times, to investigate the synergism of vitamin D3 (VD3 ) and the antagonism of verapamil (VP), and to explore the possible mechanisms. Methods:The level of HeLa cell proliferation in the presence of various factors was determined by MTT assay. The level of ^3H-TdR incorporation into the fresh human cervical cancer tissues in the presence of various stimulators was evaluated by autoradiography (ARG). Results:The results showed that calcium inhibited the proliferation of HeLa cell and the incorporation of 3 H-TdR into the cervical cancer tissues, and VD3 synergized the inhibitory effect of calcium. Calcium antagonist VP remarkably antagonized calcium-induced inhibitory effect and partly antagonized the synergism of VD3. Conclusion:Calcium could inhibit the proliferation of cervical cancer tissues and cells in a manner of dose- and time-dependent, the mechanisms of which were related with promoting the influx of extracellular calcium into cells. The synergism of VD3 is relevant not only to its facilitation of the influx of extracellular calcium into cell but also to other mechanisms, which need to be studied further.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2005年第5期403-405,共3页 Journal of China Medical University
基金 国家自然科学基金资助项目(30070849)
关键词 钙离子 维生素D3 宫颈癌 细胞增殖 calcium vitamin D3 cervical cancer cell proliferation
  • 相关文献

参考文献7

  • 1Wang X J, Xu JX. Possible involvement of Ca2+ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells[J]. Neurosci Lett, 2005,376(2) :127 - 132.
  • 2Corbett EF, Michalak M. Calcium, a signaling molecule in the endoplasmic reticulum? [J]. Trends Biochem Sci, 2000, 25(7):307 -311.
  • 3王志刚,刘丽梅.各种肿瘤患者血清钙测定结果[J].中国乡村医药,2004,11(4):47-48. 被引量:1
  • 4Kampman E, Slattery ML, Caan B, et al. Calcium, vitamin D,sunshine exposure, diary products and colon cancer risk (United States) [J]. Cancer Causes Control, 2000, 11 (5): 459 -466.
  • 5阎衡秋.维生素D及其受体与乳腺癌[J].国外医学(肿瘤学分册),2001,28(5):371-373. 被引量:4
  • 6Murthy S, Weigel NL. 1alpha, 25-dihydroxyvitamin D3 induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor beta signaling pathway [J]. Prostate,2004,59(3) :282 -291.
  • 7Nakagawa K, Kawaura A, Kato S,et al. 1alpha,25-dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer [J]. Carcinogenesis, 2005,26(2) :429 -440.

二级参考文献17

  • 1李建海.恶性肿瘤患者血清钙测定及评价[J].中国肿瘤临床与康复,1996,3(2):23-24. 被引量:3
  • 2黄培林.维生素D、钙与大肠肿瘤[J].微量元素与健康研究,1998,4:66-66.
  • 3[3]Slattery ML,Carey RN,Stone P. Dietary calcium intake as a mitigating factor in colon cancer. Am J Epidemiol, 1998,128: 504
  • 4Strugnell SA;Deluea HF.The vitamin D receptor structure and transcriptional activation,1997(03).
  • 5Narvaez CJ;Zinser G;Welsh J.Functions of 1alpha,25-dihydroxyvitamin D(3 ) in mammary gland:from normal development to breast cancer[J],2001(3-5).
  • 6Koike M;Elstner E;Campbell MJ.19-nor-hexafluoride analogue of vitamin D3:a novel class of potent inhibitors of proliferation of human breast cell lines,1997(20).
  • 7Smith EA;Frankenburg EP;Goldstein SA.Effects of longterm administration of vitamin D3 analogs to mice[J],2000(01).
  • 8Klijn JG;Setyono B;Bontenbal M.Novel endocrine therapies in breast cancer[J],1996(05).
  • 9Elstner E;Heber D;Koeffler HP.20-Epi-vitamin D3 analogs. Potent modulators of proliferation and differentiation of breast cancer cell lines in vitro,1996.
  • 10Issa LL;Leong GM;Eisman JA.Molecular mechanism of vitamin D receptor action[J],1998(12).

共引文献3

同被引文献42

  • 1郗永义,郑秀芬,叶健,霍赛虎,张健,陈帅锋.维生素D受体研究进展[J].大连医科大学学报,2004,26(3):227-230. 被引量:8
  • 2段娥,王芳,李英勇.维生素D及其受体与妇科肿瘤[J].国外医学(妇产科学分册),2005,32(4):213-216. 被引量:4
  • 3卢航青,郑杰.全反式维甲酸和1α,25二羟维生素D_3对肝癌细胞HepG2生长的协同抑制作用[J].癌症,2006,25(12):1470-1476. 被引量:12
  • 4Jurutka PW, Hsieh JC, Remus LS, et al. Mutation in the 1,25-dihydroxyvitamin D3 receptor identifying C-terminal amino acids required for transcription activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor ⅡB, in vitro[ J ]. Biol Chem, 1997, 272(23 ) : 14592-14599.
  • 5Ylikomi T, Laaksi I, Rulou Y, et al. Antiproliferative action of vitamin D[ J]. Vitam Horm,2002 ,64 :357-406.
  • 6Jehan-Kimmel C, Darwish HM, Strugnell SA ,et al. Binding of vitamin D receptor to vitamin D responsive elements induces DNA distortion [ J ]. J Bone Miner Res, 1996,11 (Suppl) : S312.
  • 7Beer TM, Myrthue A. Calcitriol in cancer treatment :from the lab to the clinic[J]. Mol Cancer Ther,2004,3(3) :373-381.
  • 8Zehnder D, Bland R, Hughes SV,et al. Analysis of the tissue distribution of I a-dihydroxylase identifies novel extra-renal sites for the synthesis of 1,25-dihydroxyvitamin D3 [M]//Norman AW, Bouillon R, Thomasset M (Eds). Vitamin D Endocrine System. Riverside : University of California, Riverside ,2000 : 159-162.
  • 9谈杨苏.晒太阳防卵巢癌[EB/OL].(2006-12-26)http://www.sxgov.cn/jksh/jbfz/387909.shtml.
  • 10Li P,Li C,Zhao X,et al. p27^Kip1 Stabilization and G1 arrest by 1 , 25-dihydroxyvitamin D3 in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1 cullin-F-box protein/Skp2 ubiquitin ligase[J]. J Biol Chem, 2004,279 ( 24 ) :25260-25267.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部